The Effects of 3% Trehalose Ophthalmic Solution on Corneal Epithelial Barrier Function

Abroad (travel likely)RecruitingPHASE4

Conditions

Dry Eye Disease (DED)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Marshall B. Ketchum University, Fullerton, California, United States
Contact: Study coordinator (Shora Ansari, OD, MS) · sansari@ketchum.edu · 714-463-7536
Contact: Principal Investigator (Shora Ansari, OD, MS)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Randomized Single Center Study to Evaluate Tolerability, Symptoms, and Visual Functional Outcomes With the Use of OTC Lubricating Eye Drops in Subjects With Dry Eye Disease

Dry Eye Disease (DED)

Abroad (travel likely)RecruitingPHASE4

Andover, United States

A Multicenter, Open-Label Study to Evaluate Perioperative Treatment of Dry Eye With Miebo® in Subjects Undergoing LASIK

Dry Eye Syndrome (DES) · Dry Eye Disease (DED)

Abroad (travel likely)RecruitingPHASE4

Bozeman, United States · Omaha, United States

SYSTANE® PRO vs. MIEBO™ in Dry Eye Disease

Dry Eye Disease (DED)

Abroad (travel likely)RecruitingPHASE4

Newport Beach, United States · Bloomington, United States

Supplementary Kelulut Honey Therapy in Juvenile Open-Angle Glaucoma: Effects on IL-6, RNFL and Dry Eye

Juvenile Open Angle Glaucoma · Dry Eye Disease (DED) · Interleukin 6

Abroad (travel likely)RecruitingPHASE4

Kota Bharu, Malaysia · Kuala Krai, Malaysia